These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30567234)

  • 21. A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
    Maung SW; Leahy M; O'Leary HM; Khan I; Cahill MR; Gilligan O; Murphy P; McPherson S; Jackson F; Ryan M; Hennessy B; McHugh J; Goodyer M; Bacon L; O'Gorman P; Nee A; O'Dwyer M; Enright H; Saunders J; O'Keeffe D
    Br J Haematol; 2013 Oct; 163(1):118-22. PubMed ID: 23909468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Warm autoimmune hemolytic anemia: advances in pathophysiology and treatment.
    Michel M
    Presse Med; 2014 Apr; 43(4 Pt 2):e97-e104. PubMed ID: 24680421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of new cold antibodies in a patient with a history of warm autoimmune haemolytic anaemia.
    Anderson M; Winter M; Jorge V; Dourado C
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32595125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial.
    Röth A; Bommer M; Hüttmann A; Herich-Terhürne D; Kuklik N; Rekowski J; Lenz V; Schrezenmeier H; Dührsen U
    Blood Adv; 2018 Oct; 2(19):2543-2549. PubMed ID: 30291112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.
    Birgens H; Frederiksen H; Hasselbalch HC; Rasmussen IH; Nielsen OJ; Kjeldsen L; Larsen H; Mourits-Andersen T; Plesner T; Rønnov-Jessen D; Vestergaard H; Klausen TW; Schöllkopf C
    Br J Haematol; 2013 Nov; 163(3):393-9. PubMed ID: 23981017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report.
    Hamilton AJ; Webb LH; Williams JK; D'Souza RJ; Ngu LS; Moore J
    BMC Nephrol; 2015 Jul; 16():108. PubMed ID: 26187383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery from delirium and psychotic manifestations following treatment of anaemia with off-label rituximab in active cold haemagglutinin disease.
    Kaklamanos M; Regmi S; Wrench D; Kinirons M
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26838299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of cold agglutinin disease associated with low-grade B-cell lymphoma in a patient receiving pembrolizumab for lung cancer.
    Karki NR; McElhone P; Savage N; Abdel Karim N
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
    D'Arena G; Califano C; Annunziata M; Tartarone A; Capalbo S; Villani O; Amendola G; Pietrantuono G; Ferrara F; Pinto A; Musto P; D'Arco AM; Cascavilla N
    Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
    Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of warm autoimmune haemolytic anaemia with intravascular haemolysis: a rare presentation.
    Gunawardena D; Gamakaranage GA
    Ceylon Med J; 2013 Dec; 58(4):176-8. PubMed ID: 24385063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases.
    Bussone G; Ribeiro E; Dechartres A; Viallard JF; Bonnotte B; Fain O; Godeau B; Michel M
    Am J Hematol; 2009 Mar; 84(3):153-7. PubMed ID: 19123460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type.
    Meyer O; Stahl D; Beckhove P; Huhn D; Salama A
    Br J Haematol; 1997 Sep; 98(4):860-2. PubMed ID: 9326179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients.
    Roumier M; Loustau V; Guillaud C; Languille L; Mahevas M; Khellaf M; Limal N; Noizat-Pirenne F; Godeau B; Michel M
    Am J Hematol; 2014 Sep; 89(9):E150-5. PubMed ID: 24847759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.
    Svahn J; Fioredda F; Calvillo M; Molinari AC; Micalizzi C; Banov L; Schmidt M; Caprino D; Marinelli D; Gallisai D; Dufour C
    Br J Haematol; 2009 Apr; 145(1):96-100. PubMed ID: 19208098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
    van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.
    Pratt G; Kinsey SE
    Bone Marrow Transplant; 2001 Oct; 28(8):791-3. PubMed ID: 11781633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
    Cheung WW; Hwang GY; Tse E; Kwong YL
    Haematologica; 2006 May; 91(5 Suppl):ECR13. PubMed ID: 16709521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy.
    Rossi P; Demoux AL; Granel B; Bagnères D; Bonin-Guillaume S; Frances Y
    Rheumatology (Oxford); 2005 Mar; 44(3):403-5. PubMed ID: 15637040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.